Evidence map›Paper›PMID 38937807›Full record

ArticleParasites & vectors2024

Next-generation neuropeptide Y receptor small-molecule agonists inhibit mosquito-biting behavior.

Emely V Zeledon, Leigh A Baxt, Tanweer A Khan, Mayako Michino, Michael Miller, David J Huggins, Caroline S Jiang, Leslie B Vosshall, Laura B Duvall

Abstract read
In one paragraph

Article in Parasites & vectors, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. mBio · 2024
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Emely V ZeledonLaboratory of Neurogenetics and Behavior, The Rockefeller University, New York, NY, 10065, USA.
Leigh A BaxtSanders Tri-Institutional Therapeutics Discovery Institute, New York, NY, 10065, USA.
Tanweer A KhanSanders Tri-Institutional Therapeutics Discovery Institute, New York, NY, 10065, USA.
Mayako MichinoSanders Tri-Institutional Therapeutics Discovery Institute, New York, NY, 10065, USA.
Michael MillerSanders Tri-Institutional Therapeutics Discovery Institute, New York, NY, 10065, USA.
David J HugginsSanders Tri-Institutional Therapeutics Discovery Institute, New York, NY, 10065, USA.
Caroline S JiangCenter for Clinical and Translational Science, The Rockefeller University, New York, NY, 10065, USA.
Leslie B VosshallLaboratory of Neurogenetics and Behavior, The Rockefeller University, New York, NY, 10065, USA.
Laura B DuvallDepartment of Biological Sciences, Columbia University, New York, NY, 10027, USA. lbd2126@columbia.edu.

Funding

Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational SuccessUL1TR001866 · NCATS · ROCKEFELLER UNIVERSITY · PI COLLER, BARRY, KRUEGER, JAMES G · 2016 to 2025
$40.6M
Peptide regulation of mosquito blood feeding and matingR35GM137888 · NIGMS · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Laura Duvall · 2020 to 2026
$2.9M
Esther A. and Joseph Klingenstein Fund Klingenstein-Simons Fellowship Award in NeuroscienceNCATS NIH HHS UL1 TR001866NIGMS NIH HHS R35 GM137888The Arnold and Mabel Beckman Foundation Beckman Young Investigator AwardThe Pew Foundation Pew Biomedical Scholars Award
6 · The paper itself

Abstract

backgroundFemale Aedes aegypti mosquitoes can spread disease-causing pathogens when they bite humans to obtain blood nutrients required for egg production. Following a complete blood meal, host-seeking is suppressed until eggs are laid. Neuropeptide Y-like receptor 7 (NPYLR7) plays a role in endogenous host-seeking suppression and previous work identified small-molecule NPYLR7 agonists that inhibit host-seeking and blood-feeding when fed to mosquitoes at high micromolar doses.

methodsUsing structure-activity relationship analysis and structure-guided design we synthesized 128 compounds with similarity to known NPYLR7 agonists.

resultsAlthough in vitro potency (EC

conclusionsExogenous activation of NPYLR7 represents an innovative vector control strategy to block mosquito biting behavior and prevent mosquito-human host interactions that lead to pathogen transmission.

Indexed as

AedesFeeding BehaviorMosquito VectorsReceptors, Neuropeptide YAnimalsFemaleHumansStructure-Activity RelationshipReceptors, Neuropeptide YAedes aegyptiHost-seekingMosquitoNeuropeptide YSmall-molecule agonistStructure-guided design

Identifiers

PMID38937807
PMCPMC11212260

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.